• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像观察到的低回声病变的灰度值与靶病变匹配对预测临床显著前列腺癌的作用。

Usefulness of grayscale values of hypoechoic lesions matched with target lesions observed on magnetic resonance imaging for the prediction of clinically significant prostate cancer.

机构信息

Department of Urology, National Health Insurance Service Ilsan Hospital, Goyang, Republic of Korea.

Department of Urology, Gangnam Severance Hospital, Urological Science Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 06273, Republic of Korea.

出版信息

BMC Urol. 2022 Oct 29;22(1):164. doi: 10.1186/s12894-022-01111-7.

DOI:10.1186/s12894-022-01111-7
PMID:36309672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9617296/
Abstract

BACKGROUND

To analyze grayscale values for hypoechoic lesions matched with target lesions evaluated using prebiopsy magnetic resonance imaging (MRI) according to the Prostate Imaging-Reporting and Data System (PI-RADS).

METHODS

We collected data on 420 target lesions in patients who underwent MRI/transrectal ultrasound fusion-targeted biopsies between January 2017 and September 2020. Images of hypoechoic lesions that matched the target lesions on MRI were stored in a picture archiving and communication system, and their grayscale values were estimated using the red/green/blue scoring method through an embedded function. We analyzed imaging data using grayscale values.

RESULTS

Of the 420 lesions, 261 (62.1%) were prostate cancer lesions. There was no difference in the median grayscale values between benign and prostate cancer lesions. However, grayscale ranges (41.8-98.5 and 42.6-91.8) were significant predictors of prostate cancer and clinically significant prostate cancer (csPC) in multivariable logistic regression analyses. Area under the curve for detecting csPC using grayscale values along with conventional variables (age, prostate-specific antigen levels, prostate volume, previous prostate biopsy results, and PI-RADS scores) was 0.839, which was significantly higher than that for detecting csPC using only conventional variables (0.828; P = 0.036). Subgroup analysis revealed a significant difference for PI-RADS 3 lesions between grayscale values for benign and cancerous lesions (74.5 vs. 58.8, P = 0.008). Grayscale values were the only significant predictive factor (odds ratio = 4.46, P = 0.005) for csPC.

CONCLUSIONS

Distribution of grayscale values according to PI-RAD 3 scores was potentially useful, and the grayscale range (42.6-91.8) was a potential predictor for csPC diagnosis.

摘要

背景

分析根据前列腺影像报告和数据系统(PI-RADS)评估的术前磁共振成像(MRI)匹配的低回声病变的灰度值。

方法

我们收集了 2017 年 1 月至 2020 年 9 月期间接受 MRI/经直肠超声融合靶向活检的 420 个靶病变患者的数据。MRI 上与靶病变匹配的低回声病变的图像存储在图像存档和通信系统中,并通过嵌入式功能使用红/绿/蓝评分法估计其灰度值。我们使用灰度值分析了影像学数据。

结果

在 420 个病变中,261 个(62.1%)为前列腺癌病变。良性和前列腺癌病变的中位灰度值无差异。然而,灰度范围(41.8-98.5 和 42.6-91.8)是多变量逻辑回归分析中前列腺癌和临床显著前列腺癌(csPC)的显著预测因子。使用灰度值结合常规变量(年龄、前列腺特异性抗原水平、前列腺体积、既往前列腺活检结果和 PI-RADS 评分)检测 csPC 的曲线下面积为 0.839,明显高于仅使用常规变量检测 csPC 的曲线下面积(0.828;P=0.036)。亚组分析显示,PI-RADS 3 病变的良性和癌性病变的灰度值有显著差异(74.5 与 58.8,P=0.008)。灰度值是 csPC 的唯一显著预测因素(优势比=4.46,P=0.005)。

结论

根据 PI-RAD 3 评分分布的灰度值可能具有一定的应用价值,灰度范围(42.6-91.8)可能是预测 csPC 的潜在指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9940/9617296/8a1ff26b62a5/12894_2022_1111_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9940/9617296/8a1ff26b62a5/12894_2022_1111_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9940/9617296/8a1ff26b62a5/12894_2022_1111_Fig1_HTML.jpg

相似文献

1
Usefulness of grayscale values of hypoechoic lesions matched with target lesions observed on magnetic resonance imaging for the prediction of clinically significant prostate cancer.磁共振成像观察到的低回声病变的灰度值与靶病变匹配对预测临床显著前列腺癌的作用。
BMC Urol. 2022 Oct 29;22(1):164. doi: 10.1186/s12894-022-01111-7.
2
Usefulness of grayscale values measuring hypoechoic lesions for predicting prostate cancer: An experimental pilot study.测量低回声病变的灰度值对预测前列腺癌的效用:一项实验性初步研究。
Prostate Int. 2022 Mar;10(1):28-33. doi: 10.1016/j.prnil.2021.11.002. Epub 2021 Dec 3.
3
Should Targeted Biopsy be Performed in Patients Who Have Only Pi-rads 3 Lesions?仅存在 PI-RADS 3 类病灶的患者是否应行靶向活检?
Arch Esp Urol. 2022 Jun;75(5):410-415. doi: 10.37554/en-j.arch.esp.urol-20210717-3506-26.
4
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.前列腺影像报告和数据系统(PI-RADS)评分与指数病变和多灶性、临床显著前列腺癌的相关性。
Eur Urol Oncol. 2018 May;1(1):29-36. doi: 10.1016/j.euo.2018.01.002. Epub 2018 May 15.
5
The role of the size and number of index lesion in the diagnosis of clinically significant prostate cancer in patients with PI-RADS 4 lesions who underwent in-bore MRI-guided prostate biopsy.在接受腔内MRI引导下前列腺活检的PI-RADS 4类病变患者中,索引病灶的大小和数量在临床显著前列腺癌诊断中的作用。
World J Urol. 2023 Feb;41(2):449-454. doi: 10.1007/s00345-022-04274-y. Epub 2023 Jan 3.
6
Impact of Lesion Visibility on Transrectal Ultrasound on the Prediction of Clinically Significant Prostate Cancer (Gleason Score 3 + 4 or Greater) with Transrectal Ultrasound-Magnetic Resonance Imaging Fusion Biopsy.经直肠超声引导下磁共振融合靶向活检预测有临床意义前列腺癌(Gleason 评分 3+4 或更高)中病灶可视性的影响。
J Urol. 2018 Mar;199(3):699-705. doi: 10.1016/j.juro.2017.09.075. Epub 2017 Sep 20.
7
The Role of Systematic and Targeted Biopsies in Light of Overlap on Magnetic Resonance Imaging Ultrasound Fusion Biopsy.磁共振成像超声融合活检中重叠现象下系统性和靶向性活检的作用。
Eur Urol Oncol. 2018 Sep;1(4):263-267. doi: 10.1016/j.euo.2018.03.009. Epub 2018 May 15.
8
Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study.定量低回声病变在预测和 Gleason 分级前列腺癌中的作用:一项前瞻性研究。
World J Urol. 2018 Jul;36(7):1059-1065. doi: 10.1007/s00345-018-2224-8. Epub 2018 Mar 5.
9
Predictive clinical features for negative histopathology of MRI/Ultrasound-fusion-guided prostate biopsy in patients with high likelihood of cancer at prostate MRI: Analysis from a urologic outpatient clinic1.基于泌尿科门诊患者的研究:磁共振成像/超声融合引导前列腺活检阴性组织学预测的临床特征在前列腺磁共振成像高度怀疑癌症患者中的分析 1.
Clin Hemorheol Microcirc. 2020;76(4):503-511. doi: 10.3233/CH-209225.
10
MRI-Ultrasound Fusion Targeted Biopsy of Prostate Imaging Reporting and Data System Version 2 Category 5 Lesions Found False-Positive at Multiparametric Prostate MRI.多参数前列腺 MRI 发现前列腺影像报告和数据系统版本 2 类别 5 病变的 MRI-超声融合靶向活检为假阳性。
AJR Am J Roentgenol. 2018 May;210(5):W218-W225. doi: 10.2214/AJR.17.18680. Epub 2018 Feb 28.

本文引用的文献

1
The Prostate Health Index aids multi-parametric MRI in diagnosing significant prostate cancer.前列腺健康指数有助于多参数 MRI 诊断显著前列腺癌。
Sci Rep. 2021 Mar 5;11(1):1286. doi: 10.1038/s41598-020-78428-6.
2
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
3
Combining clinical and MRI data to manage PI-RADS 3 lesions and reduce excessive biopsy.
结合临床和MRI数据管理PI-RADS 3类病变并减少过度活检。
Transl Androl Urol. 2020 Jun;9(3):1252-1261. doi: 10.21037/tau-19-755.
4
Multicenter analysis of clinical and MRI characteristics associated with detecting clinically significant prostate cancer in PI-RADS (v2.0) category 3 lesions.多中心分析与 PI-RADS(v2.0)分类 3 病变中检测临床显著前列腺癌相关的临床和 MRI 特征。
Urol Oncol. 2020 Jul;38(7):637.e9-637.e15. doi: 10.1016/j.urolonc.2020.03.019. Epub 2020 Apr 17.
5
Which clinical and radiological characteristics can predict clinically significant prostate cancer in PI-RADS 3 lesions? A retrospective study in a high-volume academic center.哪些临床和影像学特征可预测 PI-RADS 3 病变中的临床显著前列腺癌?高容量学术中心的回顾性研究。
Eur J Radiol. 2019 May;114:92-98. doi: 10.1016/j.ejrad.2019.02.031. Epub 2019 Feb 25.
6
Prostate cancer detection rate according to lesion visibility using ultrasound and MRI.基于超声和 MRI 下病灶可视性的前列腺癌检出率。
Clin Radiol. 2019 Jun;74(6):474-479. doi: 10.1016/j.crad.2019.02.002. Epub 2019 Mar 4.
7
Prebiopsy Biparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2: A Multicenter Study.基于 PI-RADS 版本 2 的术前双参数 MRI 对临床显著前列腺癌的检测:一项多中心研究。
AJR Am J Roentgenol. 2019 Apr;212(4):839-846. doi: 10.2214/AJR.18.20498. Epub 2019 Feb 19.
8
Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications.哪些评分需要核心?不同活检指征下 PIRADS 评分对 MR 靶向活检效能的评估。
Prostate Cancer Prostatic Dis. 2018 Nov;21(4):573-578. doi: 10.1038/s41391-018-0065-6. Epub 2018 Jul 23.
9
MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?早期前列腺癌检测中的磁共振成像:如何处理不确定或可疑的前列腺影像报告和数据系统(PI-RADS)3类病变?
Transl Androl Urol. 2018 Feb;7(1):70-82. doi: 10.21037/tau.2017.12.31.
10
Quantitation of hypoechoic lesions for the prediction and Gleason grading of prostate cancer: a prospective study.定量低回声病变在预测和 Gleason 分级前列腺癌中的作用:一项前瞻性研究。
World J Urol. 2018 Jul;36(7):1059-1065. doi: 10.1007/s00345-018-2224-8. Epub 2018 Mar 5.